24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Kadimastem
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:07
Tipalti cuts staff again as fintech shifts focus to AI and mid-market customers
19:13
A $220 million upgrade keeps Israeli missile systems at the heart of India's naval defenses
16:42
Zim posts $830 million profit as Hapag-Lloyd prepares new acquisition application
16:31
One-third of Israeli tech exits occur within five years of a company's founding
More stories
Buzz
Most popular
Daily
Weekly
1
After years in development, Elbit's airborne laser weapons move closer to production
2
The Israeli business Nvidia bought for $6.9 billion now generates $21 billion a quarter
3
Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.
4
Former Biden national security adviser Jake Sullivan and Anthropic executive Rob Bair join advisory board of VC fund New Era
5
Intel employees report new IT layoffs as restructuring continues
More news
Kadimastem
2 stories about Kadimastem
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019